| Product NDC: | 52584-011 |
| Proprietary Name: | Chloramphenicol Sodium Succinate |
| Non Proprietary Name: | Chloramphenicol Sodium Succinate |
| Active Ingredient(s): | 133.27 mg/133.27mg & nbsp; Chloramphenicol Sodium Succinate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-011 |
| Labeler Name: | General Injectables and Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062365 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100901 |
| Package NDC: | 52584-011-15 |
| Package Description: | 1 VIAL in 1 BAG (52584-011-15) > 133.27 mg in 1 VIAL |
| NDC Code | 52584-011-15 |
| Proprietary Name | Chloramphenicol Sodium Succinate |
| Package Description | 1 VIAL in 1 BAG (52584-011-15) > 133.27 mg in 1 VIAL |
| Product NDC | 52584-011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chloramphenicol Sodium Succinate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100901 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables and Vaccines, Inc |
| Substance Name | CHLORAMPHENICOL SODIUM SUCCINATE |
| Strength Number | 133.27 |
| Strength Unit | mg/133.27mg |
| Pharmaceutical Classes | Amphenicol-class Antibacterial [EPC],Amphenicols [Chemical/Ingredient] |